Cardiovascular Business

85 articles in the TruthFoundry index. Each links out to the original.

• Medtronic Receives CE Mark Approval for Endurant Stent Graft Labeling Update · Medtronic secured CE mark approval to remove a warning about ruptured AAA treatment from its Endurant stent graft system.
• FDA Authorizes Powerful Medical's Queen of Hearts AI for Heart Attack Detection · FDA grants De Novo authorization to Powerful Medical's AI model for detecting heart attacks in ECGs.
• Nurse-Coordinated Care via App Improves Heart Failure Survival · A nurse-led intervention using a mobile app significantly increased heart failure survival rates in an Indian trial.
• ESC Cardiology Conference Sets Record Attendance · The ESC cardiology conference achieved record-breaking attendance this year.
• FDA recalls Boston Scientific LUX-Dx monitors for delayed alert software issues · FDA classifies Class II recall for Boston Scientific LUX-Dx monitors due to delayed AF Burden Alerts.
• Study Links Xylitol Consumption to Higher Heart Attack and Stroke Risk · New data links high xylitol intake to significantly increased risks of heart attacks, strokes, and death.
• New Guidelines Recommend Early Rehab for Stroke Patients · American Stroke Association and American Heart Association recommend starting stroke rehab within 48 hours of medical stability.
• FDA Clears Heartvue.ai AI Software for Cardiac MRI Analysis · FDA grants clearance to Heartvue.ai's AI software for automated cardiac MRI measurements.
• SCCT Updates CCTA Guidelines with CAD-RADS 2.0 and AI Standards · SCCT releases new expert consensus on coronary CT angiography incorporating CAD-RADS 2.0 and AI tools.
• Health Equity Becomes Financial Imperative for Cardiology Systems · Cardiology leaders argue that addressing health inequities is now a critical business and clinical necessity.
• Global Experts Redefine Heart Attack Definition to Improve Women's Care · International cardiology task force updates myocardial infarction definition to address sex-specific biases and improve diagnosis.
• Surgeon Performs First US Implant of FDA-Review Heart Valve · C.S. Mott Children's Hospital performs first US implant of Autus Valve still under FDA review.
• Metformin Fails to Improve Outcomes for Heart Failure Patients · Two studies presented at ESC Congress 2026 found metformin offers no cardioprotective benefits for heart failure patients.
• Expert argues against sex-specific thresholds for coronary CT scans · Cardiologist Parwani warns that binary sex-specific thresholds for coronary CT are biologically inaccurate and calls for AI-driven risk models.
• Medtronic Invests $80M in Pi-Cardia, Options for Acquisition · Medtronic invests up to $80 million in Pi-Cardia with an option to acquire the Israeli medtech firm.
• Cardiologists Struggle to Manage Own Heart Health Despite Medical Expertise · Study reveals cardiologists face same cardiovascular barriers as the general public despite high awareness.
• Catheter-Directed Thrombolysis Improves Outcomes in High-Risk Pulmonary Embolism · PRAGUE-26 study shows catheter-directed thrombolysis reduces mortality and complications in intermediate-high risk PE patients.
• T-TEER Valve Repair Improves Survival for High-Risk Heart Patients · New data links T-TEER tricuspid valve repair to better survival and reduced heart failure risk in high-risk patients.
• AI Detects Inflammation and Stroke Risk via Cardiac CT Scans · New AI technology analyzes cardiac CT scans to detect inflammation and predict stroke risk.
• Cardiologists Question AFib Ablation Quality of Life Findings · Two cardiologists argue sham-controlled AFib ablation data may be limited by short follow-up and comparator effects.
• Targeted Lead Placement Fails to Improve Outcomes in Heart Failure CRT Patients · A large Danish trial found no benefit to targeted electrical mapping for CRT lead placement compared to standard methods.
• TAVR-First Strategy Noninferior to PCI-First for Heart Patients · New data shows treating aortic stenosis before coronary intervention is noninferior to the reverse order.
• Aficamten Shows Promise as First Treatment for Nonobstructive HCM · New trial data suggests aficamten effectively treats nonobstructive hypertrophic cardiomyopathy.
• Heartflow AI Software Cuts Unnecessary Heart Catheterizations by 44% · New trial data shows Heartflow's FFRCT Analysis reduces unnecessary invasive heart procedures by 44%.
• FDA warns of Boston Scientific catheter recall due to injury risk · FDA warns public about Boston Scientific catheters being removed due to tip detachment risks.
• GE HealthCare Unveils Three New Cardiovascular Ultrasound Systems · GE HealthCare launches Vivid Explorer, Vivid Advanced, and Vivid Focus ultrasound systems powered by AI.
• ESC Heart Failure Guidelines Overhauled for 2026 · European Society of Cardiology releases new 2026 heart failure guidelines with updated staging and prevention focus.
• Adult Congenital Heart Programs Expand as Patient Survival Rates Rise · Specialized adult congenital heart programs are growing to meet rising patient needs with improved outcomes.
• FDA Approves Tirzepatide for Cardiovascular Risk Reduction in Type 2 Diabetes · FDA approves tirzepatide to reduce cardiovascular events in adults with type 2 diabetes.
• AVID Medical Recalls Cath Lab Kits Over Particulate Risk · AVID Medical recalls cath lab kits due to safety concerns regarding Medline manifolds containing particulate.